triazoles has been researched along with h 89 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diniz, C; Fresco, P; Gonçalves, J | 1 |
Aceves, J; Erlij, D; Florán, B; Florán, L; Gonzalez, B; Paz, F | 1 |
Diógenes, MJ; Fontinha, BM; Ribeiro, JA; Sebastião, AM | 1 |
Bruzzese, L; By, Y; Condo, J; Durand-Gorde, JM; Fenouillet, E; Fromonot, J; Guieu, R; Kipson, N; Ruf, J | 1 |
Brozmanova, M; Hu, Y; Kollarik, M; Mazurova, L; Ru, F; Tatar, M; Yu, S | 1 |
Bai, W; Chen, JF; Chen, X; Chen, XY; Li, P; Liu, D; Ning, YL; Peng, Y; Wang, H; Yang, N; Zhao, Y; Zhao, ZA; Zhou, YG | 1 |
6 other study(ies) available for triazoles and h 89
Article | Year |
---|---|
Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenylyl Cyclases; Animals; Arteries; Cyclic AMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Activation; Indoles; Isoquinolines; Male; Norepinephrine; Phenethylamines; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptor, Adenosine A2A; Signal Transduction; Sulfonamides; Tail; Tetradecanoylphorbol Acetate; Triazoles; Tritium; Type C Phospholipases | 2004 |
Adenosine A2A receptor stimulation decreases GAT-1-mediated GABA uptake in the globus pallidus of the rat.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine A2 Receptor Agonists; Animals; Colforsin; Cyclic AMP-Dependent Protein Kinases; Data Interpretation, Statistical; Enzyme Inhibitors; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techniques; Isoquinolines; Male; Okadaic Acid; Phenethylamines; Rats; Rats, Wistar; Sulfonamides; Synapses; Triazines; Triazoles | 2006 |
Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Brain-Derived Neurotrophic Factor; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Data Interpretation, Statistical; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Indole Alkaloids; Isoquinolines; Long-Term Potentiation; Male; Neuroprotective Agents; Phenethylamines; Phosphorylation; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Sulfonamides; Triazoles | 2008 |
NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppression Therapy; Isoquinolines; NF-kappa B; Receptor, Adenosine A2A; Signal Transduction; Sulfites; Sulfonamides; T-Lymphocytes; Triazines; Triazoles; Up-Regulation | 2014 |
Mechanisms of the adenosine A2A receptor-induced sensitization of esophageal C fibers.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Dose-Response Relationship, Drug; Esophagus; Guinea Pigs; In Vitro Techniques; Isoquinolines; Muscle Contraction; Nerve Endings; Nerve Fibers, Unmyelinated; Neuroprotective Agents; Nodose Ganglion; Patch-Clamp Techniques; Phenethylamines; Protein Kinase Inhibitors; Purinergic P2X Receptor Agonists; Pyrimidines; Receptor, Adenosine A2A; Sulfonamides; Transient Receptor Potential Channels; Triazoles; Vagus Nerve | 2016 |
Adenosine A
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adult; Aged; Animals; Brain Injuries, Traumatic; Cognitive Dysfunction; Disease Models, Animal; Female; Glycogen Synthase Kinase 3 beta; Glycogen Synthase Kinases; Hippocampus; Humans; Indoles; Isoquinolines; Male; Maleimides; Mice; Mice, Knockout; Middle Aged; Neurons; Phenethylamines; Phosphorylation; Protein Kinase Inhibitors; Receptor, Adenosine A2A; Signal Transduction; Sulfonamides; tau Proteins; Triazines; Triazoles | 2017 |